Skip to main content
Fig. 5 | BMC Medicine

Fig. 5

From: Feasibility and outcome of reproducible clinical interpretation of high-dimensional molecular data: a comparison of two molecular tumor boards

Fig. 5

Clinical outcome. The Kaplan-Meier survival curve of 34 patients eligible for overall survival analysis revealed a significantly improved outcome for patients stratified to matched MTB therapy options (e.g., treatment recommended by both MTB), compared with those receiving treatment based on differing MTB recommendations (e.g., treatment recommended by only one MTB) or doctor’s choice (e.g., treatment not recommended by any MTB)

Back to article page